The well-defined cascade of operational procedures for production, isolation, purification, analysis, and storage of the Extracellular Vesicles (EVs) put a strong foundation for “EV๏lve” platform.
 
“EV๏lve” is a cutting-edge exosome engineering platform, which enables highly customized EV manufacturing at your desired production scale to meet your specific therapeutic or research needs and meets cGMP requirements
 
EV๏lve is a vertically integrated R&D cascade bringing unmatched efficiency:

• Environment: cGMP or non-regulated.

• Source: mesenchymal or cancer cell lines, biofluids, plants, bacteria, etc.

• Engineering: expression or depletion of desired biomarkers, fluorescent proteins, miRNA, control of lipids, etc.

• Scale: from small analytical and pilot scale projects to large industrial production.

• Purity: control of residual impurities, sterility, endotoxin, and mycoplasma testing.

• Quality Control: A full range of analytical characterization of the starting material and the product at multiple steps in the process is available and fully customizable.

• Formulation and Packaging: liquid or lyophilized product in the desired container.